LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2186-5
|
Cytochrome C oxidase
|
CCnc
|
Pt
|
WBC
|
Qn
| null |
CHEM
| 1 |
Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes
|
CyC Oxidase WBC-cCnc
| null |
ACTIVE
|
1.0
|
2.15
|
21865-1
|
Hospital.reporting
|
ID
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Hospital.reporting [Identifier] Cancer
|
Hospital.reporting Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21866-9
|
Patient ID.hospital
|
ID
|
Pt
|
^Patient
|
Nom
| null |
TUMRRGT
| 2 |
Patient ID.hospital
|
Patient ID.hospital
| null |
ACTIVE
|
1.0m
|
2.73
|
21867-7
|
Sequence number.hospital
|
Arb
|
Pt
|
Cancer.XXX
|
Ord
| null |
TUMRRGT
| 2 |
Sequence number.hospital Cancer
|
Seq #.hospital Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21868-5
|
User ID.hospital assigned
|
ID
|
Pt
|
Abstractor
|
Nom
| null |
TUMRRGT
| 2 |
User ID.hospital assigned Abstractor
|
Hospital ID Abstractor
| null |
ACTIVE
|
1.0m
|
2.73
|
21869-3
|
Hospital admission.first contact
|
TmStp
|
Pt
|
Cancer
|
Qn
| null |
TUMRRGT
| 2 |
Hospital admission.first contact [Date and time] Cancer
|
Hosp adm 1st contact Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21870-1
|
Date of inpatient admission
|
TmStp
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date of inpatient admission Cancer
|
Date of inpt adm Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21871-9
|
Date of inpatient discharge
|
TmStp
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date of inpatient discharge Cancer
|
Date of inpt disch Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21872-7
|
Relationship between this hospital and cancer Dx
|
Type
|
Episode
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Relationship between this hospital and cancer Dx
|
Rel between hosp and cancer Dx
| null |
ACTIVE
|
1.0m
|
2.32
|
2187-3
|
Cytosol aminopeptidase
|
CCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma
|
Cytosol AP SerPl-cCnc
| null |
ACTIVE
|
1.0
|
2.73
|
21873-5
|
Y first seen at this hospital for
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Year first seen at this hospital for [Date] Cancer
|
Y first seen this hospital for Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21874-3
|
Cancer conference.presentation status at reporting facility
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Cancer conference.presentation status at reporting facility
|
Presentation at CA Conf
| null |
ACTIVE
|
1.0m
|
2.32
|
21875-0
|
Cancer conference
|
TmStp
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Cancer conference [Date and time]
|
CA Conf
| null |
ACTIVE
|
1.0m
|
2.32
|
21876-8
|
Surgery procedure for primary site at facility.YYY
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery procedure for primary site at facility.YYY Cancer
|
Surg proc for prime site Cancer
| null |
ACTIVE
|
1.0m
|
2.34
|
21877-6
|
Surgery procedure for regional nodes at facility.YYY
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery procedure for regional nodes at facility.YYY Cancer
|
Surg proc for reg nodes Cancer
| null |
ACTIVE
|
1.0m
|
2.34
|
21878-4
|
Other regional disease at facility.YYY most definitive procedure
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Other regional disease at facility.YYY most definitive procedure Cancer
|
Other reg dis at facility most def proc
| null |
ACTIVE
|
1.0m
|
2.27
|
21879-2
|
Surgery.regional nodes examined at facility.YYY most definitive procedure
|
Num
|
Surg
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Surgery.regional nodes examined at facility.YYY most definitive procedure [#] Surgery Cancer
|
Surg.reg nodes exam most def proc Cancer
| null |
ACTIVE
|
1.0m
|
2.52
|
218-8
|
Demeclocycline
|
Susc
|
Pt
|
Isolate
|
OrdQn
|
Agar diffusion
|
ABXBACT
| 1 |
Demeclocycline [Susceptibility] by Disk diffusion (KB)
|
Demeclocycline Islt KB
| null |
ACTIVE
|
1.0
|
2.19
|
21880-0
|
Radiation Rx therapy
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Radiation treatment therapy Cancer
|
Radiation Rx therapy Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
2188-1
|
Cytosol aminopeptidase
|
PrThr
|
Pt
|
Urine
|
Ord
| null |
CHEM
| 1 |
Cytosol aminopeptidase [Presence] in Urine
|
Cytosol AP Ur Ql
| null |
ACTIVE
|
1.0
|
2.56
|
21881-8
|
Chemotherapy Rx at facility.YYY
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Chemotherapy treatment at facility.YYY Cancer
|
Chemotherapy Rx at facility Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21882-6
|
Hormone Rx at facility.YYY
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Hormone treatment at facility.YYY Cancer
|
Hormone Rx at facility Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21883-4
|
Transplant Rx at facility.YYY
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Transplant treatment at facility.YYY Cancer
|
Transplant Rx at facility Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21884-2
|
Other Rx at facility.YYY
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Other treatment at facility.YYY Cancer
|
Other Rx at facility Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21885-9
|
Surgery.not cancer Rx at facility.YYY
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery.not cancer treatment at facility.YYY
|
Surgery.not cancer Rx
| null |
ACTIVE
|
1.0m
|
2.34
|
21886-7
|
Breast-prostate staging.NAACCR
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Breast-prostate staging.NAACCR
|
Breast-prostate staging.NAACCR Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21887-5
|
SEER summary stage 1977
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
SEER summary stage 1977 Cancer
|
SEER SS1977 Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21888-3
|
Stage.summary abbreviated at Dx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Summary stage abbreviated at Dx Cancer
|
SS abbreviated at Dx Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21889-1
|
Size
|
Len
|
Pt
|
Tumor
|
Qn
| null |
TUMRRGT
| 2 |
Size Tumor
|
Size Tumor
| null |
ACTIVE
|
1.0m
|
2.73
|
21890-9
|
Extension
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Extension Cancer
|
Extension Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21891-7
|
Extent of disease
|
Type
|
Pt
|
Prostate cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Extent of disease Prostate cancer
|
EOD Prostate cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21892-5
|
Lymph node involvement
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Lymph node involvement Cancer
|
LN involved Cancer
| null |
ACTIVE
|
1.0m
|
2.58
|
21893-3
|
Regional lymph nodes positive
|
Num
|
Pt
|
Specimen
|
Qn
| null |
TUMRRGT
| 2 |
Regional lymph nodes positive [#] Specimen
|
Reg LN positive Spec
| null |
ACTIVE
|
1.0m
|
2.61
|
21894-1
|
Regional lymph nodes examined
|
Num
|
Pt
|
Specimen
|
Qn
| null |
TUMRRGT
| 2 |
Regional lymph nodes examined [#] Specimen
|
Reg LN examined Spec
| null |
ACTIVE
|
1.0m
|
2.56
|
21895-8
|
Extent of disease.NAACCR.old 13 digit
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Extent of disease.NAACCR.old 13 digit
|
EOD.NAACCR.old 13 digit Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21896-6
|
Extent of disease.NAACCR.old 2 digit
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Extent of disease.NAACCR.old 2 digit
|
EOD.NAACCR.old 2 digit Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21897-4
|
Extent of disease.NAACCR.old 4 digit
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Extent of disease.NAACCR.old 4 digit
|
EOD.NAACCR.old 4 digit Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21898-2
|
Version used
|
Type
|
Pt
|
Extent of disease coding system
|
Nom
| null |
TUMRRGT
| 2 |
Version used Extent of disease coding system
|
Version EOD coding sys
| null |
ACTIVE
|
1.0m
|
2.32
|
2189-9
|
Cytosol aminopeptidase
|
CCnc
|
Pt
|
Urine
|
Qn
| null |
CHEM
| 1 |
Cytosol aminopeptidase [Enzymatic activity/volume] in Urine
|
Cytosol AP Ur-cCnc
| null |
ACTIVE
|
1.0
|
2.68
|
21899-0
|
Primary tumor.pathology
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Primary tumor.pathology Cancer
|
Primary tumor.pathology Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21900-6
|
Regional lymph nodes.pathology
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Regional lymph nodes.pathology [Class] Cancer
|
Reg LN.pathology Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21901-4
|
Distant metastases.pathology
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Distant metastases.pathology [Class] Cancer
|
Distant metastases.pathology Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21902-2
|
Stage group.pathology
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Stage group.pathology Cancer
|
Stg grp.pathology Cancer
| null |
ACTIVE
|
1.0m
|
2.73
|
21903-0
|
Descriptor.pathology
|
Find
|
Pt
|
Cancer.XXX
|
Nar
| null |
TUMRRGT
| 2 |
Descriptor.pathology Cancer Narrative
|
Descript.pathology Cancer
| null |
ACTIVE
|
1.0m
|
2.40
|
21904-8
|
Stager.pathology
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Stager.pathology Cancer
|
Stager.pathology Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21905-5
|
Primary tumor.clinical
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Primary tumor.clinical [Class] Cancer
|
Primary tumor.clinical Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21906-3
|
Regional lymph nodes.clinical
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Regional lymph nodes.clinical [Class] Cancer
|
Reg LN.clinical Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
2190-7
|
Dehydroepiandrosterone sulfate
|
MCnc
|
Pt
|
Amnio fld
|
Qn
| null |
CHEM
| 1 |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid
|
DHEA-S Amn-mCnc
| null |
ACTIVE
|
1.0
|
2.42
|
21907-1
|
Distant metastases.clinical
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Distant metastases.clinical [Class] Cancer
|
Distant metastases.clinical Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21908-9
|
Stage group.clinical
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Stage group.clinical Cancer
|
Stg grp.clinical Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21909-7
|
Descriptor.clinical
|
Find
|
Pt
|
Cancer.XXX
|
Nar
| null |
TUMRRGT
| 2 |
Descriptor.clinical Cancer Narrative
|
Descript.clinical Cancer
| null |
ACTIVE
|
1.0m
|
2.40
|
21910-5
|
Stager.clinical
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Stager.clinical Cancer
|
Stager.clinical Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21911-3
|
Primary tumor.other
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Primary tumor.other [Class] Cancer
|
Primary tumor.other Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21912-1
|
Regional lymph nodes.other
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Regional lymph nodes.other [Class] Cancer
|
Reg LN.other Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21913-9
|
Distant metastases.other
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Distant metastases.other [Class] Cancer
|
Distant metastases.other Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21914-7
|
Stage group.other
|
Class
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Stage group.other Cancer
|
Stg grp.other Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
2191-5
|
Dehydroepiandrosterone sulfate
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma
|
DHEA-S SerPl-mCnc
| null |
ACTIVE
|
1.0
|
2.73
|
21915-4
|
Stager.other
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Stager.other Cancer
|
Stager.other Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21916-2
|
Descriptor.other
|
Find
|
Pt
|
Cancer.XXX
|
Nar
| null |
TUMRRGT
| 2 |
Descriptor.other Cancer Narrative
|
Descript.other Cancer
| null |
ACTIVE
|
1.0m
|
2.40
|
21917-0
|
Version used
|
ID
|
Pt
|
TNM classification
|
Nom
| null |
TUMRRGT
| 2 |
Version used [Identifier] TNM classification
|
Version TNM Classification
| null |
ACTIVE
|
1.0m
|
2.32
|
21918-8
|
Other staging classification
|
Class
|
Pt
|
Cancer.XXX
|
Nar
| null |
TUMRRGT
| 2 |
Other staging classification Cancer Narrative
|
Other staging classification Cancer
| null |
ACTIVE
|
1.0m
|
2.40
|
21919-6
|
Date 1st positive Bx
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st positive Bx Cancer
|
Date 1st positive Bx Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21920-4
|
Site of distant metastasis
|
Anat
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Site of distant metastasis Cancer
|
Site of distant mets Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21921-2
|
Pediatric stage
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Pediatric stage Cancer
|
Pediatric stage Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21922-0
|
Coding system used
|
Prid
|
Pt
|
Cancer.XXX pediatric staging
|
Nom
| null |
TUMRRGT
| 2 |
Coding system used Cancer pediatric staging
|
Coding sys used Cancer Ped stage
| null |
ACTIVE
|
1.0m
|
2.32
|
2192-3
|
Dehydroepiandrosterone sulfate
|
MRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine
|
DHEA-S 24h Ur-mRate
| null |
ACTIVE
|
1.0
|
2.73
|
21923-8
|
Pediatric cancer stager
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Pediatric cancer stager
|
Pediatric cancer stager
| null |
ACTIVE
|
1.0m
|
2.27
|
21924-6
|
Tumor marker
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Tumor marker Cancer
|
Tumor marker Cancer
| null |
ACTIVE
|
1.0m
|
2.73
|
21925-3
|
Date 1st surgery treatment
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st surgery treatment Cancer
|
Date 1st surgery Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21926-1
|
Date 1st radiation treatment
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st radiation treatment Cancer
|
Date 1st radiation Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21927-9
|
Date 1st chemotherapy treatment
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st chemotherapy treatment Cancer
|
Date 1st chemo Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21928-7
|
Date 1st hormone treatment
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st hormone treatment Cancer
|
Date 1st hormone Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21929-5
|
Date 1st immunotherapy treatment
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st immunotherapy treatment Cancer
|
Date 1st BRM Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21930-3
|
Date 1st other treatment
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st other treatment Cancer
|
Date 1st other Tx Cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
2193-1
|
Dehydroepiandrosterone
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma
|
DHEA SerPl-mCnc
| null |
ACTIVE
|
1.0
|
2.73
|
21931-1
|
Date 1st cancer Rx (any).SEERS
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st cancer treatment (any).SEERS
|
Date 1st cancer Rx (any).SEERS
| null |
ACTIVE
|
1.0m
|
2.73
|
21932-9
|
Date 1st cancer Rx (any).COC
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date 1st cancer treatment (any).COC
|
Date 1st cancer Rx (any).COC
| null |
ACTIVE
|
1.0m
|
2.50
|
21933-7
|
Date non cancer directed surgery Rx as part of 1st cancer
|
Date
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Date non cancer directed surgery treatment as part of 1st cancer
|
Date non CDS Rx as part of 1st cancer
| null |
ACTIVE
|
1.0m
|
2.50
|
21934-5
|
Surgery site.primary
|
Anat
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery site.primary Cancer
|
Surgery site.primary Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21935-2
|
Surgery scope
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery scope Cancer
|
Surgery scope Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21936-0
|
Surgery.other regional disease
|
Prid
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery.other regional disease Cancer
|
Surgery.other reg disease Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21937-8
|
Surgery regional nodes examined
|
Num
|
Pt
|
Cancer.XXX
|
Qn
| null |
TUMRRGT
| 2 |
Surgery regional nodes examined [#] Cancer
|
Surgery reg nodes examined Cancer
| null |
ACTIVE
|
1.0m
|
2.32
|
21938-6
|
Surgical approach
|
Type
|
Pt
|
Surgical procedure
|
Nom
| null |
TUMRRGT
| 2 |
Surgical approach
|
Surgical approach
| null |
ACTIVE
|
1.0m
|
2.72
|
21939-4
|
Surgical margins cancer involvement
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgical margins cancer involvement
|
Surg margins cancer invol
| null |
ACTIVE
|
1.0m
|
2.29
|
21940-2
|
Surgery reconstruction
|
Prid
|
Pt
|
Surgical procedure
|
Nom
| null |
TUMRRGT
| 2 |
Surgery reconstruction
|
Surgery reconstruction
| null |
ACTIVE
|
1.0m
|
2.72
|
21941-0
|
Reason for no cancer directed surgery
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Reason for no cancer directed surgery
|
Reason for no CDS
| null |
ACTIVE
|
1.0m
|
2.29
|
21942-8
|
Non cancer directed surgery summary
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Non cancer directed surgery summary
|
Non CDS summary
| null |
ACTIVE
|
1.0m
|
2.29
|
21943-6
|
Radiation Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Radiation treatment Cancer
|
Radiation Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21944-4
|
Lung & leukemia CNS radiation status
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Lung and leukemia CNS radiation status Cancer
|
Lung/Leukemia CNS Rad status Cancer
| null |
ACTIVE
|
1.0m
|
2.38
|
21945-1
|
Surgery-radiation sequence
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Surgery-radiation sequence Cancer
|
Surgery-radiation sequence Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21946-9
|
Chemotherapy Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Chemotherapy treatment Cancer
|
Chemotherapy Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21947-7
|
Hormone Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Hormone treatment Cancer
|
Hormone Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21948-5
|
Biological response modifier Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Biological response modifier treatment Cancer
|
Biological response modifier Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
2194-9
|
Dehydroepiandrosterone
|
PrThr
|
Pt
|
Urine
|
Ord
| null |
CHEM
| 1 |
Dehydroepiandrosterone (DHEA) [Presence] in Urine
|
DHEA Ur Ql
| null |
ACTIVE
|
1.0
|
2.73
|
21949-3
|
Other Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Other treatment Cancer
|
Other Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21950-1
|
Reason for no radiation Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Reason for no radiation treatment Cancer
|
Reason for no radiation Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21951-9
|
Reason for no chemotherapy Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Reason for no chemotherapy treatment Cancer
|
Reason for no chemotherapy Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21952-7
|
Reason for no hormone Rx
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Reason for no hormone treatment Cancer
|
Reason for no hormone Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
21953-5
|
Coding system for Rx
|
ID
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Coding system for treatment [Identifier] Cancer
|
Coding sys for Rx Cancer
| null |
ACTIVE
|
1.0m
|
2.27
|
21954-3
|
Protocol eligibility status
|
Type
|
Pt
|
Cancer.XXX
|
Nom
| null |
TUMRRGT
| 2 |
Protocol eligibility status Cancer
|
Protocol eligibility status Cancer
| null |
ACTIVE
|
1.0m
|
2.29
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.